7 psychedelic stocks to watch in 2021 | finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

Psychedelic stocks

Ready to invest in the experimental drug industry? Consider these 7 stocks.

For many investors, the experimental psychedelics industry may be too risky to invest in. Most companies in this sector are privately held, and psychedelic stocks are often volatile penny or OTC stocks.

Aside from being risky, these stocks can also be difficult to purchase. Most stocks will require you to have a brokerage account that offers access to OTC and international stocks, like Interactive Brokers or TradeStation.

For investors willing to take the risk, the best psychedelic stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

How to buy psychedelic stocks

Sign up with an online broker or platform to invest in one of more of these psychedelic stocks.
  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like CMPS or MMEDF. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Invest in the experimental drug industry today with a market order or use a limit order to delay your purchase until the stock reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy fractional shares, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of a psychedelic company. Optimize your portfolio by tracking how your stock — and even the experimental drug sector as a whole — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare psychedelic stocks

We round up a selection of stocks in or related to the experimental drug industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

1. COMPASS Pathways (CMPS)

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.

COMPASS Pathways stock opened the day at $40.90 after a previous close of $39.02. The latest price was $41.21 (25 minute delay). COMPASS Pathways is listed on the NASDAQ.

  • Market capitalization: $1,428,948,096

2. Mind Medicine MindMed (MMEDF)

Mind Medicine (MindMed) Inc. , a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.

Mind Medicine MindMed stock opened the day at $2.34 after a previous close of $2.34. The latest price was $2.24 (25 minute delay). Mind Medicine MindMed is listed on the OTCQB and employs 22 staff.

  • Market capitalization: $790,725,632

3. 20/20 Global (TWGL)

Mycotopia Therapies Inc. provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions. The company was incorporated in 2019 and is based in Aventura, Florida.

20/20 Global stock opened the day at $3.50 after a previous close of $3.50. The latest price was $3.50 (25 minute delay). 20/20 Global is listed on the PINK.

  • Market capitalization: $42,783,072
  • P/E ratio: 14.2857
  • PEG ratio: 0

4. Numinus Wellness (NUMI)

Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health.

Numinus Wellness stock opened the day at C$0.86 after a previous close of C$0.90. The latest price was C$0.83 (25 minute delay). Numinus Wellness is listed on the V and has a trailing 12-month revenue of around CAD$975,951. All prices are listed in Canadian Dollars.

  • Market capitalization: $175,443,840

5. Mindset Pharma (MSET)

Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders.

The latest price was C$0.51 (25 minute delay). Mindset Pharma is listed on the CN. All prices are listed in Canadian Dollars.

  • Market capitalization: $30,424,768

6. Cybin (CLXPF)

Cybin Inc. , a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey.

Cybin stock opened the day at $1.23 after a previous close of $1.35. The latest price was $1.17 (25 minute delay). Cybin is listed on the OTCQB and employs 6 staff.

  • Market capitalization: $193,162,192

7. Field Trip Health (FTRP)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics.

The latest price was C$5.75 (25 minute delay). Field Trip Health is listed on the CN and has a trailing 12-month revenue of around CAD$435,460. All prices are listed in Canadian Dollars.

  • Market capitalization: $226,397,760

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in psychedelic stocks.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in psychedelic stocks, keep in mind that — like any investment — psychedelic stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the experimental drug industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site